Barry S. Komm

Biochemistry, Genetics and Molecular Biology · Life Sciences

59h-index13.5kcitations192works2.82yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(127), Menopause: Health Impacts and Treatments(53), Bone Metabolism and Diseases(27), Phytoestrogen effects and research(21), Bone health and osteoporosis research(18)

Publications192 total

Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk
JCI Insight·2025· 2 citedOpen Access
Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study
Clinical Breast Cancer·2024· 3 citedOpen Access
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control
Contemporary Clinical Trials·2024Open Access
Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer
Breast Cancer Research·2024· 7 citedOpen Access
Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials
Menopause The Journal of The North American Menopause Society·2024· 2 cited
(114) Vaginal/Vulvar Symptoms with Lasofoxifene versus Fulvestrant in ESR1-mutated, ER+/HER2- Metastatic Breast Cancer Patients
The Journal of Sexual Medicine·2023· 3 citedOpen Access
Data from Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome
2023Open Access
Data from Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome
2023Open Access
Supplementary Tables 1-3 from Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome
2023Open Access
Supplementary Tables 1-3 from Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome
2023Open Access
Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells
PLoS ONE·2022· 8 citedOpen Access
Abstract P4-02-07: Lasofoxifene as a potential treatment for aromatase inhibitor resistant ER positive breast cancer
Cancer Research·2022
Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert
Menopause The Journal of The North American Menopause Society·2021· 6 citedOpen Access
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
Breast Cancer Research·2021· 82 citedOpen Access
Abstract 4370: Lasofoxifene alone or in combination with palbociclib as an effective treatment for therapy-resistant ER-positive metastatic breast cancer
Cancer Research·2020
MON-006 Progesterone Receptor Expression in Endometrial Biopsies After 12 Weeks of Exposure to A 4-µg E2 Softgel Vaginal Insert or Placebo
Journal of the Endocrine Society·2020Open Access
Lasofoxifene is an effective inhibitor of breast cancer lung and liver metastasis in a mammary intraductal (MIND) xenograft model of mutant ER[alpha]+ breast cancer
Oncology Abstracts·2019
Lasofoxifene as a potential treatment for ER+ metastatic breast cancer.
Journal of Clinical Oncology·2019· 7 cited
SUN-006 Lasofoxifene Achieves Potent Anti-Tumor Activity in Hormone-Resistant Breast Tumors by Maintaining High Affinity Binding for Y537S ERα
Journal of the Endocrine Society·2019Open Access
Abstract PD7-09: Lasofoxifene decreases breast cancer lung and liver metastasis in a mammary intraductal (MIND) xenograft model of mutant ERα+ breast cancer
Cancer Research·2019· 2 cited
page 1 of 10Next →

Frequent Co-authors

Peter V.N. Bodine(15), Benita S. Katzenellenbogen(10), C. Richard Lyttle(9), Yogendra P. Kharode(8), Jonna Frasor(6), Mark R. Haussler(6), Ramesh A. Bhat(5), Jane B. Lian(5), Ken C. N. Chang(4), Frederick J. Bex(4), Heather A. Harris(4), Robert A. Moran(4), Tripti Gaur(3), Gary S. Stein(3), Christopher Terpening(3), Gary S. Stein(3), Edmund C. Chang(3), Boris J. Cheskis(3), Chris P. Miller(3), Ruth A. Henderson(3)